The objectives of this core facility in the SPORE program are: (1) to maintain a comprehensive bank of frozen and fixed breast cancer tissues with relevant clinical and laboratory information for use by SPORE investigators and other relevant groups including other SPOREs. (2) to provide SPORE investigators expert help in conducting experiments utilizing specimens from human and animal subjects including histopathological interpretation and assistance with immunohistochemical and in-situ hybridization analyses. The services consist of two major parts: 1. collection and provision of fresh, frozen, or fixed breast cancer tissue samples with clinical follow up to the SPORE investigators. 2. provision of histopathological interpretation of the results by an expert breast pathologist on collaborative basis. The tumor bank core started its operation on Feb 1991 under the direction of Dr. Soonmyoung Paik, a board certified pathologist specializing in breast cancer. In addition to the collection of intramural tissue, we have successfully established collaborations with the Yonsei Cancer Center for fresh frozen tumors and paraffin blocks with clinical follow up. In addition, we have on-going collaborations with NCI, Howard University, NSABP, Molecular Oncology Inc., and CALGB for some of the SPORE projects and supply of materials to the tumor bank. Together, specimens with clinical follow up from a variety of sources including minority populations have been and will continue to be collected and be used in support of the SPORE projects. This core will have a close interaction with the breast cancer clinical core for clinical follow up of the cases in the tumor bank.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA058185-02
Application #
3773998
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Sharif, G M; Schmidt, M O; Yi, C et al. (2015) Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling. Oncogene 34:5879-89
Rosenfield, Sonia M; Bowden, Emma T; Cohen-Missner, Shani et al. (2012) Pleiotrophin (PTN) expression and function and in the mouse mammary gland and mammary epithelial cells. PLoS One 7:e47876
Wellstein, Anton; Toretsky, Jeffrey A (2011) Hunting ALK to feed targeted cancer therapy. Nat Med 17:290-1
Hu, Zhang-Zhi; Kagan, Benjamin L; Ariazi, Eric A et al. (2011) Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells. PLoS One 6:e20410
Stylianou, D C; Auf der Maur, A; Kodack, D P et al. (2009) Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor. Oncogene 28:3296-306
Coticchia, Christine M; Revankar, Chetana M; Deb, Tushar B et al. (2009) Calmodulin modulates Akt activity in human breast cancer cell lines. Breast Cancer Res Treat 115:545-60
Gibby, Krissa A; McDonnell, Kevin; Schmidt, Marcel O et al. (2009) A distinct role for secreted fibroblast growth factor-binding proteins in development. Proc Natl Acad Sci U S A 106:8585-90
Deb, Tushar B; Coticchia, Christine M; Barndt, Robert et al. (2008) Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation. Am J Physiol Cell Physiol 295:C365-77
Veselik, David J; Divekar, Shailaja; Dakshanamurthy, Sivanesan et al. (2008) Activation of estrogen receptor-alpha by the anion nitrite. Cancer Res 68:3950-8
Bullitt, Elizabeth; Lin, Nancy U; Smith, J Keith et al. (2007) Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: a feasibility study. Radiology 245:824-30

Showing the most recent 10 out of 117 publications